Translational Breast Cancer Research
Published by AME Publishing Company
eISSN : 2218-6778
Abbreviation : Transl. Breast Cancer Res.
Aims & Scope
ranslational Breast Cancer Research (Transl Breast Cancer Res, TBCR, Online ISSN 2218-6778) launched in November 2019, is an open-access, peer-reviewed journal focusing on translational research in breast cancer.
As a quarterly published journal, the journal seeks to create a platform for researchers and clinicians by presenting pertinent investigations, discussing critical questions relevant to the entire field of breast cancer and aiming to develop new perspectives for all those issues concerned with breast cancer.
As one of the most serious problems of oncology and the leading cause of death of women in many countries, breast cancer is truly a multidisciplinary problem to be handled.
Each issue will contain articles dealing with laboratory investigations as well as articles dealing with clinical studies.
Translational Breast Cancer Research is indexed and covered by Web of Science [Emerging Sources Citation Index (ESCI)] and PubMed/PubMed Central (PMC) and Scopus.
The journal features original articles, cutting-edge reviews, case reports and some short but thought-provoking articles like editorial commentaries, thus representing a source of valuable, novel information for clinical and basic researchers alike.
The entire submission and review process is managed through OJS, an electronic system to increase efficiency and ensure that submissions can be published within a short turnaround period.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.283 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q3 |
h-index
| Year | Value |
|---|---|
| 2024 | 6 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 17225 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 68 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.